Don't stress mate....just go and read the Shareholders letter...I think it's very comforting and we are in safe hands....
I have my own business and a successful one...nothing to do with Pharma or anything it's retail ...and whenever our individual business are not doing well the first step is get rid of old people doesn't matter how good they are or not or experienced ....nothing matters...
First step is clean up .....get new people in..new brains in and that's exactly what CG is doing....unfortunately this process takes time..
For ANP mgt and CG it will take longer....
SP does not matter at the moment...some really good discussions on our product last few days and that's what we want to know...good things about our drug and prospects...
Last 3-4 years of work has come to the final game / trial which has already started...even though not evident but Pharmas would be watching closely as ours is a platform drug with plenty of potential and don't forget it's a late stage ASSET..
Wayne and others have discussed the possibility of early approval etc...
No one wants a small company like ANP to be a leader in DMD ...tackling inflammation. As CG said progress has been made by AF but everyone wants the data which is a few months away..
From Sarepta deal with Roche, I think more interest can generate once the trial is sort of half way...Adverse event may be out of way by then as it needs to be reported ...
Pharmas can decide to compete with each other or have first mover advantage..again that's after mid way through the trial...
The road is very clear where we are going. CSL names are already flowing in steadily in our management team.
We just wait from now on ...we may have a CR soon ...even at low levels but it would be safe to have that money even though CR is at low levels...limited choice at the moment me thinks
Hence the surge and volume in SP with a little retrace on low levels seems strange...
Is CR coming??
As Sam says see how we go...
Imo dyor..
GL...
ANP Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
